FISHER SCIENTIFIC INTERNATIONAL INC 4
4 · FISHER SCIENTIFIC INTERNATIONAL INC · Filed Jun 3, 2005
Insider Transaction Report
Form 4
JELLINEK FRANK H JR
Director
Transactions
- Sale
Common Stock
2005-06-01$62.07/sh−15,000$931,026→ 77,132 total - Exercise/Conversion
Stock Options (Right to buy)
2005-06-01−3,400→ 0 totalExercise: $29.77From: 2004-08-02Exp: 2013-01-28→ Common Stock (3,400 underlying) - Exercise/Conversion
Common Stock
2005-06-01$29.77/sh+3,400$101,218→ 80,532 total - Sale
Common Stock
2005-06-01$62.13/sh−5,000$310,627→ 72,132 total - Exercise/Conversion
Common Stock
2005-06-01$35.10/sh+11,600$407,160→ 92,132 total - Exercise/Conversion
Stock Options (Right to buy)
2005-06-01−11,600→ 243,172 totalExercise: $35.10From: 2004-08-02Exp: 2008-04-27→ Common Stock (11,600 underlying)
Holdings
- 850(indirect: by 401 (k))
Common Stock
Footnotes (4)
- [F1]The exercise and sale of the option shares and directly owned shares were accomplished pursuant to a 10b5-1(c) plan adopted on December 8, 2004.
- [F2]The sales price shown is the aggregate sales price for all option shares sold on June 1, 2005, actual sales denominations are as follows: 800 shares at $62.00; 2,600 shares at $62.02; 200 shares at $62.03; 700 shares at $62.04; 8,200 shares at $62.05; 1,500 shares at $62.12; 1,000 shares at $62.35.
- [F3]The sales price shown is the aggregate sales price for 5,000 shares sold on June 1, 2005, actual sales denominations are as follows: 700 shares at $62.00; 1,700 shares at $62.05; 1,600 shares at $62.12; 1,000 shares at $62.35.
- [F4]The shares underlying the option became fully vested and exercisable upon the merger of Apogent Technologies Inc. with and into Fox Merger Corporation, a wholly owned subsidiary of Fisher Scientific International Inc., on August 2, 2004.